Related Experiment Video
Updated: Mar 19, 2026

13:15
Fabrication of Electrochemical-DNA Biosensors for the Reagentless Detection of Nucleic Acids, Proteins and Small Molecules
Published on: June 1, 2011
34.8K
An aptamer folding-based sensory platform decorated with nanoparticles for simple cocaine testing
Emine Guler1,2, Guliz Bozokalfa1, Bilal Demir1
1Ege University Faculty of Science, Biochemistry Department, 35100, Bornova, Izmir, Turkey.
Drug Testing and Analysis
|June 24, 2016
Summary
A new aptamer folding-based sensory device (AFSD) detects cocaine and its metabolite benzoylecgonine (BE) using quantum dots and gold nanoparticles. This platform shows potential for drug abuse detection and can be adapted for other addictive substances.
Area of Science:
- Analytical Chemistry
- Biotechnology
- Materials Science
Background:
- Illicit drug consumption, particularly cocaine, presents significant public health and social challenges.
- Accurate and rapid detection methods are crucial for identifying new psychoactive drugs and monitoring abuse.
- Existing detection techniques may require improvement in sensitivity and specificity for emerging substances.
Purpose of the Study:
- To develop a novel, sensitive, and selective sensory device for detecting cocaine and its primary metabolite, benzoylecgonine (BE).
- To create a combinatorial platform utilizing quantum dots (QDs) and gold nanoparticles (AuNPs) functionalized with aptamers.
- To validate the device's performance in artificial urine samples and assess its adaptability for detecting other drugs of abuse.
Main Methods:
- Fabrication of an aptamer folding-based sensory device (AFSD) by immobilizing QDs and AuNP-aptamer conjugates.
- Utilizing the fluorescence quenching of QDs upon cocaine or BE binding, which induces AuNP-QD proximity.
- Testing selectivity with various interfering substances and validating results with high-performance liquid chromatography (HPLC).
Main Results:
- The AFSD demonstrated selective detection of cocaine and BE, with linearity ranges of 1.0–10 nM and 1.0–25 µM, respectively.
- Achieved low limits of detection: 0.138 nM for cocaine and 1.66 µM for BE.
- The device performed effectively in artificial urine samples and showed good selectivity against common interfering substances.
Conclusions:
- The developed AFSD is a promising tool for cocaine abuse testing, offering high sensitivity and selectivity.
- The platform's modular design, using aptamers, allows for easy adaptation to detect a wide array of addictive drugs.
- This technology holds potential for advancing drug abuse diagnostics and monitoring.

